Market Overview:
A rapid diagnostic test is an easy and quick medical diagnostic procedure to do. Rapid diagnostic tests are ideal for quick and preliminary medical screening and are frequently used in many medical facilities with inadequate resources. If a person has some disease that has manifested itself suddenly, often without any symptoms, a rapid diagnostic test can be very useful. A fast rapid diagnostic test will give the doctor a picture of what kind of disease is present and how serious it is. If a patient comes down with a sore throat that won’t heal and isn’t accompanied by a fever, a rapid diagnostic test might be able to tell that it’s due to a cold and prescribe medication. Other things a rapid diagnostic test can tell the status of your electrolytes, such as potassium and sodium; blood pressure, and the status of liver or kidneys.
Request a Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-sample/4568
Competitive Landscape:
Major players operating in the global COVID-19 rapid diagnostic test market include R-Biopharm AG, CorDx, Euroclone SpA, LubioScience GmbH, Solus Scientific Solutions Ltd., Biosensia, Serosep Ltd., Colifast, Bactest Ltd., rqmicro AG, Gradientech, Vivione Biosciences, LLC, Rapid Micro Biosystems, Inc., Don Whitley Scientific Limited, Thermo Fisher Scientific, Inc., Sartorius AG, Quidel Corporation, NEOGEN Corporation, Merck KGaA, Danaher Corporation, Charles River Laboratories International, Inc., Bruker Corporation, bioMérieux SA, Dickinson and Company, Becton, and Abbott Laboratories, Inc.
Key Market Drivers:
The increasing prevalence of infectious diseases, such as COVID-19 in the world is the main factor that is expected to enhance the growth of the global COVID-19 rapid diagnostic test market. For instance, according to World Health Organization, in January 2021, the weekly estimation of COVID-19 cases worldwide was approximately 629,830. A rapid diagnostic test is an easy and quick diagnostic test. These tests are used for all ages, from infants to grownups.
Rapid diagnostic tests are ideal for quick initial or emergency medical screening in many medical facilities with reduced resources and quick use in specialty hospitals with fewer doctors available. Most doctors order rapid diagnostic tests before arriving in the hospital and many of them order more than one rapid diagnostic test upon arriving in the hospital. A lot of them order additional tests such as urine tests, sputum tests, blood tests, etc after seeing the initial test result. The increasing prevalence of diagnostic laboratories in the world is assessed to drive the growth of the global COVID-19 rapid diagnostic test market.
Covid-19 Impact Analysis:
The beginning of the COVID-19 pandemic has altered the delivery of medical care in the world, owing to increasing COVID positive cases in the world. For instance, according to World Health Organization, in April 2021, the weekly average of COVID cases in the world was approximately 824,881. The pandemic has highly impacted the growth of the global COVID-19 rapid diagnostic test market, as key market players have ramped up the launch of new products and services.
Get PDF Brochure with Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4568
Key Takeaways:
The size of the global COVID-19 rapid diagnostic test market was assessed at around US$ 4.2 billion in 2021, and increasing at a CAGR of 9.4% is projected to reach around US$ 6.7 billion, owing to the increasing prevalence of infectious diseases in the world, along with new launches by key market players. For instance, in October 2020, Mammoth Biosciences and Merck KGAA collaborated for the commercial production, scale-up, and development of CRISPR- based SARS-COV-2 diagnostic test.
North America is expected to hold a major share of the global COVID-19 rapid diagnostic test market, owing to increasing cases of COVID-19 pandemic in the region. For instance, according to the New York Times, the 7-day average of COVID cases in the United States, in January 2021, was around 253,946.
Asia Pacific is estimated to witness high growth in the global COVID-19 rapid diagnostic test market, owing to the increasing investment in the healthcare sector in the developing nations of the region. Moreover, the prevalence of key market players in the region is expected to propel the growth of the market.
Reasons to Purchase this Report
• Current and future of global COVID-19 Rapid Diagnostic Test market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Sample Type
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Market Dynamics
- Global COVID-19 Rapid Diagnostic Test Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global COVID-19 Rapid Diagnostic Test Market, By Product Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global COVID-19 Rapid Diagnostic Test Market, By Sample Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Nasopharyngeal (NP) Swabs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Oropharyngeal (OP) Swabs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Nasal Swabs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others (others include Saliva)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global COVID-19 Rapid Diagnostic Test Market, By Test Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Molecular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Antigen-based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Antibody Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others (others include CRISPR and Biosensors)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global COVID-19 Rapid Diagnostic Test Market, By End User, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital & Clinic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Laboratories & Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global COVID-19 Rapid Diagnostic Test Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Sample Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cardinal Health
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Alfa Scientific Designs Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Danaher
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Artron Laboratories Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Trinity Biotech
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- bioMérieux SA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Creative Diagnostics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ACON Laboratories Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sight Diagnostics Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Meridian Bioscience
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Quest Diagnostics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Perkin Elmer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Luminex Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Laboratory Corporation of America Holdings
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Veredus Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837